Hepatitis B virus inhibition in mice by lentiviral vector mediated short hairpin RNA

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages 73-

  Deng, Lei ^a   Li, Guoqiang ^a   Xi, Lisen ^a   Yin, Aihong ^a   Gao, Yun ^a   You, Wei ^a   Wang, Xuehao ^a   Sun, Beicheng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LENTIVIRUS VECTOR; MESSENGER RNA; SHORT HAIRPIN RNA; VIRUS DNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; FEMALE; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VIVO STUDY; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; PLASMID; RNA INTERFERENCE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; GENETIC VECTORS; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; LENTIVIRUS; LIVER; MICE; MICE, INBRED NOD; MICE, SCID; RNA INTERFERENCE; RNA, VIRAL; VIRUS REPLICATION;

EID: 70449512070     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-73     Document Type: Article

References (49)

1. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64(1):51-68. 10.1128/MMBR.64.1.51-68.2000, 98986, 10704474.
2. Lau GK. Hepatitis B infection in China. Clin Liver Dis 2001, 5(2):361-379. 10.1016/S1089-3261(05)70170-7, 11385968.
3. Dienstag JL, Cianciara J, Karayalcin S, Kowdley KV, Willems B, Plisek S, Woessner M, Gardner S, Schiff E. Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology 2003, 37(4):748-755. 10.1053/jhep.2003.50117, 12668966.
4. Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003, 348(9):808-816. 10.1056/NEJMoa020681, 12606735.
5. Lin OS, Keeffe EB. Current treatment strategies for chronic hepatitis B and C. Annu Rev Med 2001, 52:29-49. 10.1146/annurev.med.52.1.29, 11160766.
6. Lai CL, Rosmawati M, Lao J, Van Vlierberghe H, Anderson FH, Thomas N, Dehertogh D. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology 2002, 123(6):1831-1838. 10.1053/gast.2002.37058, 12454840.
7. Takahashi H, Fujimoto J, Hanada S, Isselbacher KJ. Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc Natl Acad Sci USA 1995, 92(5):1470-1474. 10.1073/pnas.92.5.1470, 42541, 7878002.
8. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001, 15(2):188-200. 10.1101/gad.862301, 312613, 11157775.
9. Carmona S, Ely A, Crowther C, Moolla N, Salazar FH, Marion PL, Ferry N, Weinberg MS, Arbuthnot P. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol Ther 2006, 13(2):411-421. 10.1016/j.ymthe.2005.10.013, 16337206.
10. Peng J, Zhao Y, Mai J, Pang WK, Wei X, Zhang P, Xu Y. Inhibition of hepatitis B virus replication by various RNAi constructs and their pharmacodynamic properties. J Gen Virol 2005, 86(Pt 12):3227-3234. 10.1099/vir.0.81171-0, 16298967.
11. Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 2003, 37(4):764-770. 10.1053/jhep.2003.50146, 12668968.
12. Capodici J, Kariko K, Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol 2002, 169(9):5196-5201.
13. Coburn GA, Cullen BR. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002, 76(18):9225-9231. 10.1128/JVI.76.18.9225-9231.2002, 136455, 12186906.
14. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002, 418(6896):435-438. 10.1038/nature00896, 12087358.
15. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interference in adult mice. Nature 2002, 418(6893):38-39. 10.1038/418038a, 12097900.
16. Novina CD, Murray MF, Dykxhoorn DM, Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P, Sharp PA. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002, 8(7):681-686.
17. Lee NS, Dohjima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P, Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002, 20(5):500-505.
18. Kapadia SB, Brideau-Andersen A, Chisari FV. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA 2003, 100(4):2014-2018. 10.1073/pnas.252783999, 149950, 12566571.
19. Wilson JA, Jayasena S, Khvorova A, Sabatinos S, Rodrigue-Gervais IG, Arya S, Sarangi F, Harris-Brandts M, Beaulieu S, Richardson CD. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc Natl Acad Sci USA 2003, 100(5):2783-2788. 10.1073/pnas.252758799, 151418, 12594341.
20. Randall G, Grakoui A, Rice CM. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci USA 2003, 100(1):235-240. 10.1073/pnas.0235524100, 140937, 12518066.
21. Uprichard SL, Boyd B, Althage A, Chisari FV. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc Natl Acad Sci USA 2005, 102(3):773-778. 10.1073/pnas.0409028102, 545555, 15640346.
22. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990, 10(8):4239-4242. 360961, 2370865.
23. Verma IM. Gene therapy: hopes, hypes, and hurdles. Mol Med 1994, 1(1):2-3. 2229927, 8790596.
24. Buchschacher GL, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood 2000, 95(8):2499-2504.
25. Follenzi A, Battaglia M, Lombardo A, Annoni A, Roncarolo MG, Naldini L. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 2004, 103(10):3700-3709. 10.1182/blood-2003-09-3217, 14701690.
26. Chen Y, Du D, Wu J, Chan CP, Tan Y, Kung HF, He ML. Inhibition of hepatitis B virus replication by stably expressed shRNA. Biochem Biophys Res Commun 2003, 311(2):398-404. 10.1016/j.bbrc.2003.10.009, 14592428.
27. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, Wieland SF, Marion PL, Kay MA. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003, 21(6):639-644. 10.1038/nbt824, 12740585.
28. Wu Y, Huang AL, Tang N, Zhang BQ, Lu NF. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice. Chin Med J (Engl) 2005, 118(16):1351-1356.
29. Ying RS, Zhu C, Fan XG, Li N, Tian XF, Liu HB, Zhang BX. Hepatitis B virus is inhibited by RNA interference in cell culture and in mice. Antiviral Res 2007, 73(1):24-30. 10.1016/j.antiviral.2006.05.022, 16844238.
30. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003, 77(16):8957-8961. 10.1128/JVI.77.16.8957-8951.2003, 167245, 12885912.
31. Li MJ, Rossi JJ. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes. Methods Enzymol 2005, 392:218-226. 10.1016/S0076-6879(04)92013-7, 15644184.
32. Fang J, Hodivala-Dilke K, Johnson BD, Du LM, Hynes RO, White GC, Wilcox DA. Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia. Blood 2005, 106(8):2671-2679. 10.1182/blood-2004-12-4619, 1895311, 15972454.
33. Yang PL, Althage A, Chung J, Chisari FV. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci USA 2002, 99(21):13825-13830. 10.1073/pnas.202398599, 129782, 12374864.
34. Park F, Ohashi K, Kay MA. The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo. Mol Ther 2003, 8(2):314-323. 10.1016/S1525-0016(03)00169-2, 12907154.
35. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther 1999, 6(7):1258-1266. 10.1038/sj.gt.3300947, 10455434.
36. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999, 10(10):1735-1737. 10.1089/10430349950017734, 10428218.
37. Radhakrishnan SK, Layden TJ, Gartel AL. RNA interference as a new strategy against viral hepatitis. Virology 2004, 323(2):173-181. 10.1016/j.virol.2004.02.021, 15193913.
38. Seppen J, Rijnberg M, Cooreman MP, Oude Elferink RP. Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. J Hepatol 2002, 36(4):459-465. 10.1016/S0168-8278(01)00308-7, 11943415.
39. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002, 3(10):737-747. 10.1038/nrg908, 12360232.
40. Jia F, Zhang YZ, Liu CM. A retrovirus-based system to stably silence hepatitis B virus genes by RNA interference. Biotechnol Lett 2006, 28(20):1679-1685. 10.1007/s10529-006-9138-z, 16900331.
41. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996, 93(21):11382-11388. 10.1073/pnas.93.21.11382, 38066, 8876144.
42. Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997, 17(3):314-317. 10.1038/ng1197-314, 9354796.
43. Uchida N, Sutton RE, Friera AM, He D, Reitsma MJ, Chang WC, Veres G, Scollay R, Weissman IL. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc Natl Acad Sci USA 1998, 95(20):11939-11944. 10.1073/pnas.95.20.11939, 21744, 9751769.
44. Li MJ, Bauer G, Michienzi A, Yee JK, Lee NS, Kim J, Li S, Castanotto D, Zaia J, Rossi JJ. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol Ther 2003, 8(2):196-206. 10.1016/S1525-0016(03)00165-5, 12907142.
45. Qin XF, An DS, Chen IS, Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2003, 100(1):183-188. 10.1073/pnas.232688199, 140921, 12518064.
46. Scherr M, Battmer K, Ganser A, Eder M. Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA. Cell Cycle 2003, 2(3):251-257.
47. Pfeifer A, Kessler T, Yang M, Baranov E, Kootstra N, Cheresh DA, Hoffman RM, Verma IM. Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol Ther 2001, 3(3):319-322. 10.1006/mthe.2001.0276, 11273773.
48. Follenzi A, Sabatino G, Lombardo A, Boccaccio C, Naldini L. Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum Gene Ther 2002, 13(2):243-260. 10.1089/10430340252769770, 11812281.
49. Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 2003, 8(5):769-776. 10.1016/S1525-0016(03)00244-2, 14599810.